Skip to main content
. 2014 Apr 14;82(2):423–440. doi: 10.3797/scipharm.1301-27

Tab. 6.

Evaluation of floating and pulsatile release tablets

Sr. No. Formulations Hardness (kg/cm2) Friability (%) % Drug content
1 C2+B4 3.9±0.16 0.45±0.13 99.24±1.1
2 C6+B4 4.3±0.18 0.48±0.11 99.48±2.2
3 C9+4 4.0±0.14 0.56±0.48 99.56±3.1